Your browser doesn't support javascript.
loading
Ocrelizumab extended-interval dosing in multiple sclerosis during SARS-CoV-2 pandemic: a real-world experience.
Guerrieri, Simone; Bucca, Chiara; Nozzolillo, Agostino; Genchi, Angela; Zanetta, Chiara; Cetta, Ilaria; Rugarli, Giulia; Gattuso, Irene; Azzimonti, Matteo; Rocca, Maria Assunta; Moiola, Lucia; Filippi, Massimo.
Afiliación
  • Guerrieri S; Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Bucca C; Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Nozzolillo A; Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Genchi A; Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Zanetta C; Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Cetta I; Neurorehabilitation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Rugarli G; Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Gattuso I; Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Azzimonti M; Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Rocca MA; Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Moiola L; Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Filippi M; Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Eur J Neurol ; 30(9): 2859-2864, 2023 09.
Article en En | MEDLINE | ID: mdl-37227923
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Esclerosis Múltiple Crónica Progresiva / Esclerosis Múltiple Recurrente-Remitente / COVID-19 / Esclerosis Múltiple Tipo de estudio: Observational_studies Límite: Humans Idioma: En Revista: Eur J Neurol Asunto de la revista: NEUROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Esclerosis Múltiple Crónica Progresiva / Esclerosis Múltiple Recurrente-Remitente / COVID-19 / Esclerosis Múltiple Tipo de estudio: Observational_studies Límite: Humans Idioma: En Revista: Eur J Neurol Asunto de la revista: NEUROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Italia